Avita Medical Other Assets Over Time

RCEL Stock  USD 13.34  0.47  3.65%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Avita Medical Performance and Avita Medical Correlation.
For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.
  
The value of Other Assets is estimated to slide to 2.18.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avita Medical. If investors know Avita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avita Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.23)
Revenue Per Share
2.335
Quarterly Revenue Growth
0.432
Return On Assets
(0.45)
Return On Equity
(1.52)
The market value of Avita Medical is measured differently than its book value, which is the value of Avita that is recorded on the company's balance sheet. Investors also form their own opinion of Avita Medical's value that differs from its market value or its book value, called intrinsic value, which is Avita Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avita Medical's market value can be influenced by many factors that don't directly affect Avita Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avita Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Avita Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avita Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Other Assets Analysis

Compare Avita Medical and related stocks such as Telesis Bio, Clearpoint Neuro, and Sight Sciences Other Assets Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Stock Based Compensation To RevenueCapex To Depreciation
Pb RatioEv To Sales
Free Cash Flow Per ShareRoic
Inventory TurnoverNet Income Per Share
Days Of Inventory On HandPayables Turnover
Sales General And Administrative To RevenueResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D AAverage Payables
Average InventoryAverage Receivables
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
201020112012201320142015201620172018201920202021202220232024
CLPT964.4 K964.4 K964.4 K964.4 K964.4 K964.4 K987.5 K883.5 K824.4 K722 K3.7 M644 K581 K668.1 K1.3 M
SGHT62 K62 K62 K62 K62 K62 K62 K62 K62 K168 K386 K202 K211 K242.7 K226.4 K
TMCI146 K146 K146 K146 K146 K146 K146 K146 K146 K146 K146 K146 K146 K131.4 K116.8 K
RXST983 K983 K983 K983 K983 K983 K983 K983 K983 K983 K571 K925 K1.5 M1.8 M1.1 M
AXGN37 K295 K1.3 M1.1 M794 K846 K0.00.010001000100010001000900855
LUNG206.7 K206.7 K206.7 K206.7 K206.7 K206.7 K291.6 K350 K350 K2.1 M536 K731 K5.8 M1.00.95
OFIX371 K21.9 M31.2 M29.9 M27.5 M76.8 M67.8 M44.4 M54.6 M41 M47.3 M23.9 M12.8 M14.8 M28.8 M
VREX9.1 M9.1 M9.1 M9.1 M13.9 M8.9 M9.4 M11 M27.5 M32.7 M32.7 M(13.2 M)(13.2 M)(15.2 M)(14.4 M)
APYX354 K2.3 M2.8 M4.2 M580 K578 K212 K2.2 M305 K191 K1.5 M1.1 M1.2 M1.4 M1.1 M
SIBN274 K274 K274 K274 K319 K1.9 M457 K309 K325 K315 K374 K400 K375 K337.5 K406.6 K
IRMD16 K16 K16 KK97 K192.3 K963.2 K1.2 M1.2 M1.9 M6.4 M966.4 K1.3 M1.00.95
TELA24 K24 K24 K24 K24 K24 K24 K24 K24 K24 K24 K24 K24 K21.6 K19.2 K
CVRX26 K26 K26 K26 K26 K26 K26 K26 K26 K26 K26 K26 K27 K31.1 K28.9 K
NPCE25 K25 K25 K25 K25 K25 K25 K25 K25 K25 K873 K134.3 M490 K563.5 K535.3 K
TMDX561 K518 K518 K518 K518 K518 K518 K506 K3.9 M506 K506 K500 K500 K450 K748.6 K
DCTH946 K946 K946 K946 K946 K946 K946 K946 K946 K946 K946 K1.01.00.90.86

Avita Medical and related stocks such as Telesis Bio, Clearpoint Neuro, and Sight Sciences Other Assets description

My Equities

My Current Equities and Potential Positions

Avita Medical
RCEL
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
LocationCalifornia; U.S.A
ExchangeNASDAQ Exchange
USD 13.34
When determining whether Avita Medical is a strong investment it is important to analyze Avita Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Avita Medical's future performance. For an informed investment choice regarding Avita Stock, refer to the following important reports:
Check out Avita Medical Performance and Avita Medical Correlation.
For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Avita Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Avita Medical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Avita Medical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...